Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival-Reference-Cited by-同舟云学术

Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival

Published:2018-06-25 Issue:2 Volume:101 Page:237-244
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Turesson Ingemar¹^ORCID,Bjorkholm Magnus²,Blimark Cecilie Hveding³,Kristinsson Sigurdur⁴,Velez Ramon⁵,Landgren Ola⁶

Affiliation:

1. Department of Haematology; Skane University Hospital; Malmo Sweden

2. Department of Medicine; Division of Hematology; Karolinska University Hospital and Karolinska Institutet; Stockholm Sweden

3. Department of Hematology; Sahlgrenska University Hospital and Institution of Internal Medicine; Sahlgrenska Academy at University of Gothenburg; Gothenburg Sweden

4. Department of Medicine; University of Iceland; Reykjavik Iceland

5. Department of Medicine; Section on General Internal Medicine; Wake Forest School of Medicine; Winston Salem NC USA

6. Myeloma Service; Division of Hematologic Oncology; Memorial Sloan-Kettering Cancer Center; New York NY USA

Funder

Memorial Sloan-Kettering Cancer Center

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.13083/fullpdf

Reference49 articles.

1. Multiple myeloma: a review of the epidemiologic literature;Alexander;Int J Cancer,2012

2. Incidence of multiple myeloma in Olmsted County, Minnesota. Trend over 6 decades;Kyle;Cancer,2014

3. Patterns of Multiple Myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the Clinic;Turesson;Mayo Clin Proc,2010

4. Outcome and survival of myeloma patients diagnosed 2008-2015. Real world data on 4904 patients from the Swedish Myeloma Registry (SMR);Blimark;Haematologica,2017

5. 2016 US lymphoid malignancy statistics by world health organization subtypes;Teras;CA Cancer J Clin,2016

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Strategies and Future Directions in Multiple Myeloma: Disease Overview and Pathophysiology, Conventional Treatments and Emerging Therapies, Challenges and Innovations in Management;European Journal of Medical and Health Research;2024-09-01

2. A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: From molecular interactions to potential therapeutic targets;Pathology - Research and Practice;2024-08

3. EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma;Blood;2024-07-25

4. The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge;Clinical Hematology International;2024-07-23

5. The impact of continuous lenalidomide maintenance treatment on people living with multiple myeloma—a single-centre, qualitative service evaluation study;Supportive Care in Cancer;2024-07